Cart
sales@molnova.com
(-)-Sparteine sulfate pentahydrate
CAS No. 6160-12-9
(-)-Sparteine sulfate pentahydrate( —— )
Catalog No. M15325 CAS No. 6160-12-9
Sparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. It is an alkaloid and can be extracted from scotch broom.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 70 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(-)-Sparteine sulfate pentahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. It is an alkaloid and can be extracted from scotch broom.
-
DescriptionSparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. It is an alkaloid and can be extracted from scotch broom. It is the predominant alkaloid in Lupinus mutabilis, and is thought to chelate the bivalents calcium and magnesium. It is not FDA approved for human use as an antiarrhythmic agent, and it is not included in the Vaughn Williams classification of antiarrhythmic drugs.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP2D
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number6160-12-9
-
Formula Weight422.54
-
Molecular FormulaC15H38N2O9S
-
Purity>98% (HPLC)
-
SolubilityWater: 0.1 g/mL
-
SMILESC1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4[C@H]3CCCC4.O.O.O.O.O.OS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Preissner S, et al. Nucleic Acids Res. 2010 Jan; 38(Database issue):D237-43.
molnova catalog
related products
-
Uniconazole
Uniconazole is a plant growth regulator that inhibit cytochrome P450 707As (Ki=68 nM).
-
Quinidine sulfate
Quinidine sulfate dihydrate is a potent and selective cytochrome P450db??inhibitor.
-
Ambroxol
Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
